Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open‐label, randomized controlled trial (BEYOND VII)

AIM: To determine the safety of a higher starting dose of basal insulin in overweight/obese patients with type 2 diabetes (T2D). MATERIALS AND METHODS: This 16‐week, randomized, multicentre, open‐label trial enrolled adults with T2D (body mass index 25–40 kg/m(2)) and suboptimal glycaemic control (g...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Linong, Wan, Hailong, Wen, Binhong, Wang, Xueying, Wang, Junfen, Bian, Rongwen, Pang, Wuyan, Tian, Jian, Wang, Yan, Bian, Fang, Gao, Zhengnan, Condoleon, Alex, Feng, Wei, Zhang, Xia, Cui, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187195/
https://www.ncbi.nlm.nih.gov/pubmed/31944546
http://dx.doi.org/10.1111/dom.13967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187195/
https://www.ncbi.nlm.nih.gov/pubmed/31944546
http://dx.doi.org/10.1111/dom.13967

Ejemplares similares